Short answer. The policy's tenth condition says the drug still has to meet the other applicable requirements, including section 503A's patient-specific prescription requirement [2]. The announcement did not create an over-the-counter path. As of Oct 29, 2026.

What 503A already required

The policy's background says a drug product has to be compounded based on receipt of a valid patient-specific prescription to qualify for the 503A exemptions [2]. Those exemptions, when they apply, are from FDA approval before marketing, from the usual adequate-directions labeling rule, and from full manufacturing-practice requirements [2]. They are exemptions with conditions. They are not approval.

The Oct 28 notice does not delete that prescription line. It says HHS does not intend to take action against a state-licensed pharmacy, a federal facility, or a licensed physician, and only in the circumstances the policy describes [1]. A licensed physician can compound under 503A. A text thread cannot.

What a prescription is not

A checkout box is not a prescription. A quiz on a research-chemical site is not a prescription. "My friend is a nurse" is not a prescription. The prescription is for a named patient, and a clinician is accountable for whether it is appropriate.

Sommar Club does not prescribe or sell BPC-157, TB-500, MOTS-c, epitalon, semax, or KPV. This policy does not change that. Sermorelin is a different peptide and is not in Appendix A [2]. Questions about sermorelin belong on the sermorelin page, with a clinician.

FAQ

Can I buy one of the six without a prescription because of the news? The policy we read still includes the patient-specific prescription requirement [2].

Does a prescription mean FDA approved it? No. Compounded drugs are not FDA-approved even when a prescription is valid [1].

Sources

1. HHS notice, FR Doc. 2026-22192, filed Oct 28, 2026. https://public-inspection.federalregister.gov/2026-22192.pdf

2. HHS policy, background on 503A and condition 10. https://www.hhs.gov/sites/default/files/hhs-503a-peptide-enforcement-discretion-policy-appendix-b.pdf

Education only. Not medical or legal advice. As of Oct 29, 2026.